BOGGIANI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 400
EU - Europa 328
AS - Asia 259
SA - Sud America 44
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.040
Nazione #
US - Stati Uniti d'America 391
SG - Singapore 112
IE - Irlanda 95
CN - Cina 83
SE - Svezia 62
IT - Italia 50
BR - Brasile 42
HK - Hong Kong 42
DE - Germania 41
NL - Olanda 18
GB - Regno Unito 13
FR - Francia 9
FI - Finlandia 8
IN - India 8
BE - Belgio 7
CA - Canada 7
RU - Federazione Russa 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
TR - Turchia 6
AT - Austria 4
LT - Lituania 4
ES - Italia 3
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
CO - Colombia 1
IL - Israele 1
IQ - Iraq 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
SN - Senegal 1
VN - Vietnam 1
Totale 1.040
Città #
Dublin 95
Chandler 94
Singapore 72
Santa Clara 50
Hong Kong 41
Ashburn 40
Shanghai 29
Beijing 28
Boardman 19
New York 13
Bremen 12
Munich 12
Princeton 12
Seattle 12
Ann Arbor 11
Parma 10
Dearborn 8
Des Moines 8
Wilmington 8
Brussels 7
Helsinki 7
Ravenna 7
Abidjan 6
Frankfurt am Main 6
Los Angeles 6
Nuremberg 5
Olomouc 5
Ardea 4
Brooklyn 4
Cascina 4
Moscow 4
Bologna 3
Columbus 3
Phoenix 3
São Paulo 3
Toronto 3
Verona 3
Belo Horizonte 2
Bexley 2
Blumenau 2
Falls Church 2
Fremont 2
Hefei 2
Hyderabad 2
Istanbul 2
Lauterbourg 2
London 2
Marseille 2
Montreal 2
Nanchang 2
Pavia 2
Rio Saliceto 2
Rio de Janeiro 2
Rome 2
The Dalles 2
Abu Dhabi 1
Almaty 1
Amsterdam 1
Anajatuba 1
Aparecida de Goiânia 1
Araripina 1
Atibaia 1
Bauru 1
Bengaluru 1
Berlin 1
Betim 1
Boa Vista do Buricá 1
Boston 1
Campinas 1
Campos dos Goytacazes 1
Canoinhas 1
Caxias do Sul 1
Charleston 1
Chennai 1
Colombo 1
Corbélia 1
Curitiba 1
Curvelo 1
Dakar 1
Dracena 1
Düsseldorf 1
Edinburgh 1
Erbil 1
Fairfield 1
Fernando de la Mora 1
Guangzhou 1
Guaratinguetá 1
Hangzhou 1
Hebei 1
Huizen 1
Izmir 1
Jiaxing 1
João Pessoa 1
Karachi 1
Kocaeli 1
Kunming 1
Lindenhurst 1
Luislândia 1
Macaé 1
Madrid 1
Totale 738
Nome #
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 89
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 87
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 83
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 79
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 77
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 74
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 69
Risk of breast cancer in ovarian cancer patients non-carriers of BRCA1 and BRCA2 mutations with a family history of breast and ovarian cancer: A population-based cancer registry study 65
Mechanism of action and clinical efficacy of CDK4/6 inhibitors in BRCA-mutated, estrogen receptor-positive breast cancers: Case report and literature review 65
Prognostic role of immunoglobulin g fragment c receptor polymorphisms in solid tumors 64
EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations 61
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 59
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 53
Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2 positive breast cancers 46
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 39
Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study 38
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy 18
Totale 1.066
Categoria #
all - tutte 5.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 2 5 0 3 3 6 9 7 4 2 1 1
2021/202244 0 1 5 0 2 0 3 4 1 0 1 27
2022/2023315 25 34 19 22 34 33 2 23 112 1 8 2
2023/2024137 2 14 1 2 3 22 10 22 4 18 22 17
2024/2025435 23 20 25 29 46 40 17 23 55 47 34 76
2025/202630 30 0 0 0 0 0 0 0 0 0 0 0
Totale 1.066